Sex differences in HIV-associated cognitive impairment
- PMID: 30407251
- PMCID: PMC6396274
- DOI: 10.1097/QAD.0000000000002012
Sex differences in HIV-associated cognitive impairment
Abstract
Objective: We determined whether there are sex differences in the prevalence and profile of HIV-associated neurocognitive impairment, and whether sex moderates the effect of HIV-serostatus on neurocognitive impairment among HIV-positive and HIV-negative individuals. Secondarily, we assessed whether differences were explained by greater biopsychosocial risk factors in HIV-positive women.
Design: An observational cohort study.
Methods: Analyses included 1361 HIV-positive (204 women) and 702 HIV-negative (214 women) (ages = 18-79 years) participants from the UCSD HIV Neurobehavioral Research Program. Demographically corrected standardized T-scores from 15 neuropsychological tests were used to calculate domain-specific and global deficit scores (GDS). GDS at least 0.5 defined neurocognitive impairment. Biopsychosocial risk factors included low education, low reading level (education quality), lifetime substance use disorders, depressed mood (clinically significant depressive symptoms and/or current major depressive disorder) and a cumulative syndemic count (sum of biopsychosocial risk factors, range = 0-4). Race-stratified analyses were conducted. Analyses were adjusted for relevant demographic and clinical factors.
Results: HIV-associated neurocognitive impairment was more prevalent in women versus men; however, the difference was eliminated after adjustment for reading level. In sex-stratified logistic regressions, the association between HIV-seropositivity and higher likelihood of neurocognitive impairment was stronger in women versus men; however, the association was attenuated in women, but not men, after adjusting for reading level. These results in the overall sample were specific to blacks. Sex differences in the profile of HIV-associated neurocognitive impairment varied by race.
Conclusion: Women, particularly black women, were most at-risk for HIV-associated neurocognitive impairment. Higher rates of HIV-associated neurocognitive impairment in women versus men may reflect differences in educational quality.
Conflict of interest statement
Conflicts of Interest
The authors have no conflicts of interest to declare.
Similar articles
-
Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.J Clin Exp Neuropsychol. 2017 Oct;39(8):753-767. doi: 10.1080/13803395.2016.1263282. Epub 2017 Jan 4. J Clin Exp Neuropsychol. 2017. PMID: 28052738
-
Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):274-283. doi: 10.1097/QAI.0000000000002029. J Acquir Immune Defic Syndr. 2019. PMID: 30893126 Free PMC article.
-
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.AIDS. 2021 Jan 1;35(1):63-72. doi: 10.1097/QAD.0000000000002709. AIDS. 2021. PMID: 33048883
-
Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.AIDS Behav. 2021 Mar;25(3):917-960. doi: 10.1007/s10461-020-03053-3. Epub 2020 Oct 6. AIDS Behav. 2021. PMID: 33025390 Free PMC article.
-
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.J Neurovirol. 2019 Oct;25(5):710-721. doi: 10.1007/s13365-018-0706-5. Epub 2019 Jan 11. J Neurovirol. 2019. PMID: 30635846 Review.
Cited by
-
People with HIV exhibit spectrally distinct patterns of rhythmic cortical activity serving cognitive flexibility.Neurobiol Dis. 2024 Oct 15;201:106680. doi: 10.1016/j.nbd.2024.106680. Epub 2024 Sep 24. Neurobiol Dis. 2024. PMID: 39326464 Free PMC article.
-
Endolysosome Localization of ERα Is Involved in the Protective Effect of 17α-Estradiol against HIV-1 gp120-Induced Neuronal Injury.J Neurosci. 2021 Dec 15;41(50):10365-10381. doi: 10.1523/JNEUROSCI.1475-21.2021. Epub 2021 Nov 11. J Neurosci. 2021. PMID: 34764157 Free PMC article.
-
Genetic variation in alcohol dehydrogenase is associated with neurocognition in men with HIV and history of alcohol use disorder: preliminary findings.J Neurovirol. 2020 Apr;26(2):214-225. doi: 10.1007/s13365-019-00825-z. Epub 2020 Jan 13. J Neurovirol. 2020. PMID: 31933193 Free PMC article.
-
Neuroimaging and Cognitive Evidence for Combined HIV-Alcohol Effects on the Central Nervous System: A Review.Alcohol Clin Exp Res. 2021 Feb;45(2):290-306. doi: 10.1111/acer.14530. Epub 2020 Dec 30. Alcohol Clin Exp Res. 2021. PMID: 33296091 Free PMC article.
-
Cocaine Use May Moderate the Associations of HIV and Female Sex with Neurocognitive Impairment in a Predominantly African American Population Disproportionately Impacted by HIV and Substance Use.AIDS Patient Care STDS. 2023 May;37(5):243-252. doi: 10.1089/apc.2023.0006. Epub 2023 Apr 20. AIDS Patient Care STDS. 2023. PMID: 37083446 Free PMC article.
References
-
- Chiesi A, Vella S, Dally LG, et al. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11(1):39–44. - PubMed
-
- Robertson KR, Kapoor C, Robertson WT, Fiscus S, Ford S, Hall CD. No gender differences in the progression of nervous system disease in HIV infection. J Acquir Immune Defic Syndr 2004; 36(3):817–22. - PubMed